s.radich
TL2 Moderator · Medellín
Contributes reviews on supplier material. Based in Medellín.
Joined 1 September 2025 · last posted 1d
84Posts here
1Topics
2Solutions
1.2kLikes received
1.4kLikes given
23Badges
233Days visited
5.3kPosts read
Recent activity
Full stream-
Travelling with an injectable: documentation and practicalities Replied, post #43 · Access › International · 27 Jul 2026 · 25 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Journal club: STEP 1 and the treatment-policy estimand Replied, post #3 · Evidence › Journal club · 18 Jul 2026 · 19 likes I read the opening post twice before replying, because I had assumed the opposite. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Alcohol: what is documented and what is folklore Replied, post #119 · Practice › Interactions · 18 Jul 2026 · 0 likes This follows post #116 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #90 · Start Here › Welcome · 17 Jul 2026 · 32 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #105 · Evidence › Preprints · 13 Jul 2026 · 0 likes On post #101 — agreed on the reasoning, with one qualification. Check whether it was later published: searching for the preprint's first author and keywords in PubMed…
-
What to bring: records that a clinician can actually use — a second dataset Started this topic · Clinical › Prescriber conversations · 1 Jul 2026 · 38 likes What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #21 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #54 · Evidence › Journal club · 23 Jun 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Why the timeline is on the right and not the left — what changed since Replied, post #59 · Meta › Site feedback · 21 Jun 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Racemisation and why it is invisible to a mass measurement Replied, post #62 · Analytics › Impurities & related substances · 12 Jun 2026 · 0 likes Coming back to post #60, because the follow-up matters more than the original answer. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #38 · Compounds › Oral incretins · 12 Jun 2026 · 3 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #45 · Analytics › Home & field testing · 12 Jun 2026 · 10 likes Picking up post #42: that is the part I would want checked first. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear…